Discovery of Triazolyl Derivatives of Cucurbitacin B Targeting IGF2BP1 against Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Discovery of Triazolyl Derivatives of Cucurbitacin B Targeting IGF2BP1 against Non-Small Cell Lung Cancer

Published:2023-09-08 Issue:18 Volume:66 Page:12931-12949
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Shang Fan-Fan¹²,Lu Qing²,Lin Tailiang²,Pu Miaoxia¹³,Xiao Ruoxuan²,Liu Wanmei²,Deng Hao¹,Guo Hongyan¹,Quan Zhe-Shan¹^ORCID,Ding Chunyong²^ORCID,Shen Qing-Kun¹

Affiliation:

1. Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji 133002, China

2. Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China

3. Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Integration Science, Yanbian University, Yanji 133002, China

Funder

Shanghai Jiao Tong University

Yanbian University

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00872

Reference40 articles.

1. Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity

2. Emerging Role of Terpenoids for the Treatment of Cancer: A Review

3. Cucurbitacin B and cancer intervention: Chemistry, biology and mechanisms (Review)

4. Cucurbitacins and cucurbitane glycosides: structures and biological activities

5. Biological activities and potential molecular targets of cucurbitacins